Human immunodeficiency virus type 1 and mucosal humoral defense

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 3, 1999, Pages

  Janoff, Edward N ^a,b   Scamurra, Ronald W ^a   Sanneman, Thomas C ^a   Eidman, Keith ^a   Thurn, Joseph R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

B LYMPHOCYTE; BREAST MILK; CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; MUCOSAL IMMUNITY; OPPORTUNISTIC INFECTION; PATHOGENESIS; PRIORITY JOURNAL; SALIVA; SERUM; VIRUS TRANSMISSION;

FEMALE; GENES, IMMUNOGLOBULIN; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULINS; MALE;

EID: 0032895731     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314813     Document Type: Conference Paper

References (21)

1. 1. Royce RA, Sena A, Cates W Jr. Choen MS. Sexual transmission of HIV. N Engl J Med 1997; 336:1072-8.
2. 2. Bélec L, Dupré T, Prazuck T, et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995; 172:691-7.
3. 3. Janoff EN, Jackson S, Wahl SM, Thomas K, Peterman JH, Smith PD. Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection. J Infect Dis 1994; 170:299-307.
4. 4. Opstad NL, Daley CL, Thurn JR, et al. Impact of Streptococcus pneumoniae bacteremia and human immunodeficiency virus type 1 on oral mucosal immunity. J Infect Dis 1995; 172:566-70.
5. 5. Eriksson K, Kilander A, Hagberg L, Norkrans G, Holmgren J, Czerkinsky C. Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individuals. AIDS 1995; 9:695-700.
6. 6. Kotler DP, Scholes JV, Tierney AR. Intestinal plasma cell alterations in acquired immunodeficiency syndrome. Dig Dis Sci 1987; 32:129-38.
7. 7. Janoff EN, Smith PD, Blaser MJ. Acute antibody responses to Giardia lamblia are depressed in patients with AIDS. J Infect Dis 1988; 157:798-804.
8. 8. Mazanec MB, Nedrud JG, Kaetzel CS, Lamm ME. A three-tiered view of the role of IgA in mucosal defense. Immunol Today 1993; 14:430-4.
9. 9. Burnett, PR, VanCott TC, Polonis VR. Serum IgA-mediated neutralization of HIV type 1. J Immunol 1994; 152:4642-8.
10. 10. Janoff EN, Wahl SM, Thomas K, Smith PD. Modulation of human immunodeficiency virus type 1 infection of human monocytes by IgA. J Infect Dis 1995; 172:855-88.
11. 11. Kozlowski PA, Black KP, Shen L, Jackson S. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. J Immunol 1995; 154:6163-73.
12. 12. Kliks SC, Wara DW, Landers, DV, Levy JA. Features of HIV-1 that could influence maternal-child transmission. JAMA 1994; 272:467-74.
13. 13. Nielsen K, Boyer P, Dillon M, et al. Presence of human immunodeficiency virus (HIV) type 1 and HIV-1 specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants. J Infect Dis 1996; 173:1001-4.
14. 14. Van de Perre P, Simonon A, Hitimana DG, et al. Infective and anti-infective properties of breast milk from HIV-1 infected women. Lancet 1993; 341: 914-8.
15. 15. Black KP, Cummins JE Jr, Jackson S. Serum and secretory IgA from HIV-infected individuals mediate antibody-dependent cellular cytotoxicity. Clin Immunol Immunopathol 1996; 81:182-90.
16. 16. Jehuda-Cohen T, Slade BA, Powell JD, et al. Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1 seronegative individuals. Proc Natl Acad Sci USA 1990; 87: 3972-6.
17. 17. Zuhler RH, Perrin LH, Doucet A, Zhang X, Huang YP, Miescher PA. Frequencies of HIV-reactive B cells in seropositive and seronegative individuals. Clin Exp Immunol 1992; 87:31-6.
18. 18. Peters MG, Secrist H, Anders KR, Nash GS, Rich SR, MacDermott RP. Normal human intestinal B lymphocytes. Increased activation compared with peripheral blood. J Clin Invest 1989; 83:1827-33.
19. 19. McCabe RP, Carroll WL, Egan M, Cohn SM, Peters M. Immunoglobulin variable region usage in human intestinal B lymphocytes. Clin Immunol Immunopathol 1994; 71:240-5.
20. 20. Wisnewski A, Cavacini L, Posner M. Human antibody variable region gene usage in HIV-infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:31-8.
21. H3 gene products: natural ligands for HIV gp120. Science 1993; 261:1588-91.